Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hirt

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Transplantation|January 3, 2014
Everolimus in heart transplantation: an updateStephan W Hirt, Christoph Bara, Markus J Barten, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 22, 2012
Successful coronary artery bypass grafting with the aid of a portable minimized extracorporeal life support systemAssad Haneya, Alois Philipp, Daniele Camboni, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 7, 2013
Impact of minimized extracorporeal circulation on outcome in patients with preoperative anemia undergoing coronary artery bypass surgeryAssad Haneya, Alois Philipp, Marietta Von Suesskind-Schwendi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 8, 2013
Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survivalG Schiechl, S M Brunner, R Kesselring, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2019
Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA studyMarkus J Barten, Stephan W Hirt, Jens Garbade, et al.
Contemporary Clinical Trials|September 13, 2015
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantationTobias Deuse, Christoph Bara, Markus J Barten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2016
Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis DevelopmentG Schiechl, F J Hermann, M Rodriguez Gomez, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Transplantation|January 3, 2014
Everolimus in heart transplantation: an updateStephan W Hirt, Christoph Bara, Markus J Barten, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 22, 2012
Successful coronary artery bypass grafting with the aid of a portable minimized extracorporeal life support systemAssad Haneya, Alois Philipp, Daniele Camboni, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 7, 2013
Impact of minimized extracorporeal circulation on outcome in patients with preoperative anemia undergoing coronary artery bypass surgeryAssad Haneya, Alois Philipp, Marietta Von Suesskind-Schwendi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 8, 2013
Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survivalG Schiechl, S M Brunner, R Kesselring, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2019
Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA studyMarkus J Barten, Stephan W Hirt, Jens Garbade, et al.
Contemporary Clinical Trials|September 13, 2015
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantationTobias Deuse, Christoph Bara, Markus J Barten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2016
Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis DevelopmentG Schiechl, F J Hermann, M Rodriguez Gomez, et al.
Pageof 8